Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Doximity (DOCS) EBITDA (2020 - 2025)

Doximity has reported EBITDA over the past 6 years, most recently at $71.9 million for Q4 2025.

  • Quarterly EBITDA fell 10.05% to $71.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $238.8 million through Dec 2025, up 8.06% year-over-year, with the annual reading at $227.8 million for FY2025, 39.01% up from the prior year.
  • EBITDA was $71.9 million for Q4 2025 at Doximity, up from $63.7 million in the prior quarter.
  • Over five years, EBITDA peaked at $79.9 million in Q4 2024 and troughed at $21.7 million in Q2 2022.
  • The 5-year median for EBITDA is $37.1 million (2021), against an average of $42.2 million.
  • Year-over-year, EBITDA skyrocketed 1094.19% in 2021 and then fell 12.84% in 2022.
  • A 5-year view of EBITDA shows it stood at $35.8 million in 2021, then grew by 7.53% to $38.5 million in 2022, then surged by 52.14% to $58.6 million in 2023, then soared by 36.5% to $79.9 million in 2024, then fell by 10.05% to $71.9 million in 2025.
  • Per Business Quant, the three most recent readings for DOCS's EBITDA are $71.9 million (Q4 2025), $63.7 million (Q3 2025), and $54.5 million (Q2 2025).